{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Centene Corp. Hits Day High with 12.5% Surge in Strong Intraday Performance
Centene Corp. has seen notable stock activity, achieving a significant intraday high while outperforming the S&P 500 over the past week and month. Despite recent gains, the company has struggled over the past year, with a substantial decline compared to the broader market. Financial metrics indicate a strong balance sheet.
Centene Corp. Hits Day High with Strong 5.11% Intraday Surge
Centene Corp. has experienced significant stock activity, gaining 5.11% on October 3, 2025, with an intraday high of USD 38.85. Despite recent gains, the company faces long-term performance challenges, including a one-year decline of 46.28%. It maintains a P/E ratio of 8.00 and a return on equity of 7.71%.
Centene Corp. Hits Day High with Strong 5.8% Intraday Surge
Centene Corp. experienced a notable stock price increase on September 24, 2025, reaching an intraday high. However, the company has faced significant challenges over the past year, with a substantial decline in stock value. Its financial metrics indicate low valuation and no current dividends for shareholders.
Is Centene Corp. technically bullish or bearish?
As of September 9, 2025, Centene Corp. is in a mildly bearish trend, with mixed technical indicators and significant underperformance compared to the S&P 500, showing a year-to-date return of -46.90% versus the S&P's 12.22%.
Is Centene Corp. overvalued or undervalued?
As of July 25, 2025, Centene Corp. is considered fairly valued but appears overvalued with a P/E ratio of 8 compared to Humana's 37.35, and has underperformed the S&P 500 with a year-to-date return of -46.90%.
Is Centene Corp. overvalued or undervalued?
As of October 1, 2023, Centene Corp. is considered an attractive investment due to its undervalued status, with a price-to-earnings ratio of 12.5, a price-to-book ratio of 1.2, and a return on equity of 15%, especially when compared to peers like UnitedHealth Group and Anthem Inc.
Is Centene Corp. technically bullish or bearish?
As of October 1, 2023, there is not enough technical data on Centene Corp. to determine if it is bullish or bearish.
Who are in the management team of Centene Corp.?
As of March 2022, Centene Corp.'s management team is led by Mr. Michael Neidorff as Chairman, President, and CEO, with independent directors including Mr. Orlando Ayala, Ms. Jessica Blume, Mr. H. James Dallas, Mr. Robert Ditmore (also Presiding Independent Director), and Mr. Frederick Eppinger.
What does Centene Corp. do?
Centene Corporation is a healthcare company that offers services primarily to government-sponsored programs for under-insured and uninsured individuals, with a market cap of approximately $28.27 billion. As of March 2025, it reported a net profit of $1.31 billion and key metrics include a P/E ratio of 8.00 and a return on equity of 12.43%.
How big is Centene Corp.?
As of Jun 18, Centene Corp. has a market capitalization of $28.27 billion. As of Dec 24, the company reported shareholder's funds of $26.41 billion and total assets of $83.58 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
